SUMMARY The effects of single intravenous injections of 1 u/kg body weight Boots and 1 u/kg GIH secretin were compared in 10 male control subjects and five men with chronic pancreatitis. The duodenum was aspirated for the next hour in 4 x 10 minute and 1 x 20 minute fractions, and the volume, bicarbonate concentration, and tryptic activity were measured.
potency in the Swedish reference standard of socretin, the potency of the clinical unit of pure Jorpes and Mutt secretin was greater than the old clinical unit by a factor at first thought to be x 2 (Jorpes and Mutt, 1965) , later x 3 to x 7 in the rat and x 4 to x 5 in the cat (Heatley, 1968) , x 8 to x 9 in the dog (Stening, Vagne, and Grossman, 1968) , and x 10 in the cat (Konturek, 1969) .
We have therefore compared 1 so-called u/kg of Boots and GIH secretin in men with and without chronic pancreatitis, both to study the relative stimulatoryeffects of these two secretins in these doses, and also to compare the diagnostic discrimination between a dose of secretin (1 u/kg Boots) known to be submaximal (Bordalo, Teixeira, and Sakelarides, 1969) and a dose of secretin (1 u/kg GIH) which is known to be near maximal (Petersen, 1970 
TIMING
In seven subjects the two tests were done on different days. In the other eight the two tests were done on the same day, the other secretin being administered only after the volume of duodenal aspirate had returned to basal levels, in an attempt to minimize any effect of the first injection on the response to the second (Henriksen, 1966; Wormsley, 1969 (TABLE I) The pancreatic juice volume in one hour after the intravenous injection of GIH secretin, 1 u/kg, was nearly double the response to Boots secretin, 1 u/kg (Figs. 1-2) . Maximum bicarbonate concentration was insignificantly higher (Fig. 3) , and peak bicarbonate output correspondingly almost twice as great after GIH than after Boots secretion 1 u/kg (Figs. 4-5) . The one-hour tryptic activity after GIH secretin was significantly lower than after Boots secretin (Figs.  6-7) . The coefficients of variation of these measurements of pancreatic juice were not appreciably improved with either secretin by expression of the results in terms of body weight.
PATIENTS WITH CHRONIC PANCREATITIS (TABLE II): COMPARISON OF THE TWO SECRETINS
The volume response to GIH secretin was about one-fifth higher than to Boots secretin, but the maximum bicarbonate concentration was more than doubled, so that peak bicarbonate output after GIH secretin was about three and one-half times that after Boots secretin.
COMPARISON OF PATIENTS WITH PANCREATITIS WITH NORMAL SUBJECTS
The diagnostic discrimination for each measurement can be estimated (Fig. 1-7) . Thus for juice volume in one hour the GIH secretin dose provided absolute discrimination between the two groups, whereas one of the patients with chronic pancreatitis fell within the normal range for the dose of Boots secretin ( Figs.  1 and 2 ). On the other hand. for maximum bicarbonate concentration, the dose of Boots secretin provided absolute discrimination, whereas one of the patients with chronic pancreatitis fell within the normal range for the dose of GIH secretin (Fig. 3) . Peak bicarbonate output in response to either secretin provided absolute discrimination (Figs. 4 and 5) . The tryptic output after the dose of Boots secretin provided absolute discrimination, whereas after the dose of GIH secretin there was almost complete overlap between the two groups (Figs. 6 and 7) . The diagnostic discrimination was not improved by expression of the results on a body-weight basis (Figs. 2 and 7) .
The secretory responses to this dose of 1 u/kg Boots secretin are comparable to other reported data (such as Sun, 1963; Hansky, 1971) and less than the responses to a higher dose of 1.7 u/kg (Burton, Evans, Harper, Mowat, Oleesky, Scott, and Varley, 1960) . The responses to 1 clinical u/kg GIH secretin are similar to those reported by Petersen (1970) and Konturek (1970) . In the present study each patient received both secretins and it seems clear that 1 clinical u/kg GIH secretin elicited a secretory response from the normal human pancreas almost double that for 1 u/kg Boots secretin. No direct comparison of the potency of the two secretins can be made since dose-response curves were not done for each secretin in each subject. It is therefore not possible to estimate from these results what dose of Boots secretin would be needed in man to stimulate a pancreatic secretion equivalent to that evoked by 1 clinical u/kg GIH secretin, nor, conversely, what dose of GIH secretin is equivalent in man to 1 u/kg Boots secretin. The greater enzyme response to Boots secretin is presumably due to its considerable content ofpancreozymnin, which may vary from batchto batch.
DIAGNOSTIC DISCRIMINATION
There is no general agreement whether the diagnostic discrimination between normal subjects and patients withchronic pancreatitis is best witha submaximal or with a maximal dose of secretin. Agren and Lagerlof (1936) believe that in pathological conditions . . . a subnormal function will be easier detected after submaximal stimulation.' In the next 30 years there were many studies of the diagnostic discrimination of a submaximal dose of secretin (see Dreiling and Janowitz, 1962) . With the demonstration of a maximum alkaline (bicarbonate) output of the dog pancreas, it was suggested that 'the measurement of maximum secretory capacity in man may allow more quantitative assessment of a secretory impairment' (Baron, Perrier, Janowitz, and Dreiling, 1963) . There have been many human studies of this augmented secretin test with either Boots (Banwell, Northam, and Cooke, 1967; Pascal, Sannou, and Ribet, 1968; Bordalo et al, 1969; Hansky, 1971) , Vitrum (Perrier, 1966; Hartley, Gambill, Engstrom, and Summerskill, 1966; Sarles, Prezlin, Souville, and Figarella, 1966; Lagerlof, Schiitz, and Holmer, 1967) or GIH secretin (Wormsley, 1968; Petersen, 1970) .
There is now evidence (Baron, 1970 ) that a maximal gastric stimulus may allow greater diagnostic discrimination between normal gastric secretion and gastric hypersecretion (as in duodenal ulcer). The studies cited above suggest that an augmented secretin stimulus of maximum bicarbonate output may allow greater diagnostic discrimination than a submaximal stimulus between normal pancreatic secretion and pancreatic hyposecretion (as in pancreatitis). However, in none of these series were the same subjects given both a submaximal and a maximal stimulus.
The present results suggest that measurements of bicarbonate concentration or enzyme output which were of some use as diagnostic discriminants in the submaximal test using Boots 1 u/kg are of little value with the test using a near-maximal stimulus of 1 clinical u/kg GIH secretin. Measurement of maximal bicarbonate output is probably the best diagnostic discriminant between normal subjects and patients with pancreatitis (Wormsley, 1970) but the present series is too small to allow a definite preference for the near maximal stimulus. The support of the Wellcome Trust is gratefully acknowledged.
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